Search Results - "Kasiske, B.L."

Mammalian Target of Rapamycin Inhibitor Dyslipidemia in Kidney Transplant Recipients by Kasiske, B. L., de Mattos, A., Flechner, S. M., Gallon, L., Meier‐Kriesche, H.‐U., Weir, M. R., Wilkinson, A.

“…The incidence, pathogenesis, consequences and treatment of mammalian target of rapamycin (mTOR) inhibitor dyslipidemia are not well described. We conducted a…”
Get full text

Use of Cardioprotective Medications in Kidney Transplant Recipients by Gaston, R. S., Kasiske, B. L., Fieberg, A. M., Leduc, R., Cosio, F. C., Gourishankar, S., Halloran, P., Hunsicker, L., Rush, D., Matas, A. J.

“…Death with function causes half of late kidney transplant failures, and cardiovascular disease (CVD) is the most common cause of death in these patients. We…”
Get full text

Regional Variability in Liver Waiting List Removals Causes False Ascertainment of Waiting List Deaths by Voigt, M. D., Hunsicker, L. G., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Inconsistent identification of reasons for removal from the liver transplant waiting list by Organ Procurement and Transplantation Network (OPTN) regions may…”
Get full text

Variation in Comedication Use According to Kidney Transplant Immunosuppressive Regimens: Application of Integrated Registry and Pharmacy Claims Data by Lentine, K.L, Naik, A.S, Schnitzler, M, Axelrod, D, Chen, J, Brennan, D.C, Segev, D.L, Kasiske, B.L, Randall, H, Dharnidharka, V.R

“…Abstract Background Modern immunosuppression therapies (ISx) have many side effects, and transplant recipients must take an array of “comedications” to help…”
Get full text

The Geography of Kidney Transplantation in the United States by Kasiske, B. L., Snyder, J. J., Skeans, M. A., Tuomari, A. V., Maclean, J. R., Israni, A. K.

“…The distance kidney transplant patients live from the centers where they undergo transplantation could affect long‐term care and outcomes, but little is known…”
Get full text

Inhibition of the mevalonate pathway: benefits beyond cholesterol reduction? by Massy, Z A, Keane, W F, Kasiske, B L

Get more information

OPTN/SRTR 2018 Annual Data Report: Kidney by Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Castro, S., Foutz, J., Wainright, J. L., Snyder, J. J., Kasiske, B. L., Israni, A. K.

“…Despite the ongoing severe mismatch between organ need and supply, data from 2018 revealed some promising trends. For the fourth year in a row, the number of…”
Get full text

OPTN/SRTR 2020 Annual Data Report: Heart by Colvin, M., Smith, J. M., Ahn, Y., Skeans, M. A., Messick, E., Bradbrook, K., Gauntt, K., Israni, A. K., Snyder, J. J., Kasiske, B. L.

“…As we enter the third year of the new adult heart allocation policy, we are faced with the new challenges of the COVID‐19 pandemic. In 2020, new listings…”
Get full text

OPTN/SRTR 2020 Annual Data Report: Liver by Kwong, A. J., Ebel, N. H., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Foutz, J., Gauntt, K., Cafarella, M., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…This year was marked by the COVID‐19 pandemic, which altered transplant program activity and affected waitlist and transplant outcomes. Still, 8906 liver…”
Get full text

OPTN/SRTR 2016 Annual Data Report: Kidney by Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Robinson, A., Wainright, J. L., Haynes, C. R., Snyder, J. J., Kasiske, B. L., Israni, A. K.

“…Data from 2016 show ongoing positive trends in short‐ and long‐term allograft survival, and a decrease in the number of active listed candi‐ dates for the…”
Get full text

OPTN/SRTR 2018 Annual Data Report: Heart by Colvin, M., Smith, J. M., Hadley, N., Skeans, M. A., Uccellini, K., Goff, R., Foutz, J., Israni, A. K., Snyder, J. J., Kasiske, B. L.

“…The new adult heart allocation policy was approved in 2016 and implemented in October 2018, so its effect was not yet evident in 2018 data. However, the more…”
Get full text

OPTN/SRTR 2017 Annual Data Report: Kidney by Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Wilk, A. R., Castro, S., Robinson, A., Wainright, J. L., Snyder, J. J., Kasiske, B. L., Israni, A. K.

“…Many positive trends in kidney transplantation were notable in 2017. Deceased donor kidney transplant rates and counts continued to rise, the kidney transplant…”
Get full text

OPTN/SRTR 2019 Annual Data Report: Liver by Kwong, A. J., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Foutz, J., Booker, S. E., Cafarella, M., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…This year was notable for changes to exception points determined by the geographic median allocation Model for End‐Stage Liver Disease (MELD) and…”
Get full text

OPTN/SRTR 2019 Annual Data Report: Lung by Valapour, M., Lehr, C. J., Skeans, M. A., Smith, J. M., Miller, E., Goff, R., Foutz, J., Israni, A. K., Snyder, J. J., Kasiske, B. L.

“…The number of lung transplants performed continues to increase annually and reached an all‐time high in 2019, with decreasing waitlist mortality. These trends…”
Get full text

OPTN/SRTR 2018 Annual Data Report: Liver by Kwong, A., Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Foutz, J., Miller, E., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Data on adult liver transplants performed in the US in 2018 are notable for (1) continued growth in numbers of new waitlist registrants (11,844) and…”
Get full text

OPTN/SRTR 2016 Annual Data Report: Liver by Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Harper, A. M., Wainright, J. L., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Data on adult liver transplants performed in the US in 2016 are no‐table for (1) the largest total number of transplants performed (7841); (2) the shortest…”
Get full text

OPTN/SRTR 2019 Annual Data Report: Heart by Colvin, M., Smith, J. M., Ahn, Y., Skeans, M. A., Messick, E., Goff, R., Bradbrook, K, Foutz, J., Israni, A. K., Snyder, J. J., Kasiske, B. L.

“…The new adult heart allocation policy was approved in 2016 and implemented in October 2018. This year's Annual Data Report provides early insight into the…”
Get full text

OPTN/SRTR 2017 Annual Data Report: Liver by Kim, W. R., Lake, J. R., Smith, J. M., Schladt, D. P., Skeans, M. A., Noreen, S. M., Robinson, A. M., Miller, E., Snyder, J. J., Israni, A. K., Kasiske, B. L.

“…Data on adult liver transplants performed in the US in 2017 are notable for (1) continued growth in numbers of new waitlist registrants (11,514) and of…”
Get full text

OPTN/SRTR 2015 Annual Data Report: Kidney by Hart, A., Smith, J. M., Skeans, M. A., Gustafson, S. K., Stewart, D. E., Cherikh, W. S., Wainright, J. L., Kucheryavaya, A., Woodbury, M., Snyder, J. J., Kasiske, B. L., Israni, A. K.

“…The first full year of data after implementation of the new kidney allocation system reveals an increase in deceased donor kidney transplants among black…”
Get full text

OPTN/SRTR 2018 Annual Data Report: Lung by Valapour, M., Lehr, C. J., Skeans, M. A., Smith, J. M., Uccellini, K., Goff, R., Foutz, J., Israni, A. K., Snyder, J. J., Kasiske, B. L.

“…The primary goal of US lung allocation policy is to ensure that candidates with the highest risk for mortality receive appropriate access to lung transplant…”
Get full text